IGIB and the Serum Institute of India aims to make sickle cell treatment accessible to India's tribal communities, where the ...
When Amy Cohen, 29, finished the New York City Marathon, she broke ground as the first person with the illness to run the 26.2 mile race ...
The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell therapies, and precision medicine driving innovation. Increased awareness and ...
Cohen, 29, ran the New York City Marathon on Nov. 2 with NYRR's Team Inspire and now feels “at peace” Her accomplishment will “help our sickle cell warriors achieve whatever they want,” Dr. Sharl Azar ...
Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the ...
The Oak Ridger on MSN
Can microbes thrive under industrial conditions to make biofuel?
Scientists are genetically engineering microbes to withstand industrial conditions for biofuel production. Researchers found ...
Deoxyribonucleic acid, or DNA, holds the responsibility to carry genetic instructions that further go on to define physical ...
Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.
In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...
Discover how scientists are harnessing the power of CRISPR to precisely edit DNA, revolutionizing medicine and ethics as they rewrite the very code of life. Pixabay, PublicDomainPictures CRISPR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback